Cargando…
Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
INTRODUCTION: We carried out an economic analysis to assess the cost-effectiveness of highly active antiretroviral therapy (HAART) regimens in Italy for the management of human immunodeficiency virus (HIV)-infected patients according to clinical practice in the Infectious Diseases Department of “L....
Autores principales: | Rizzardini, Giuliano, Bonfanti, Paolo, Carenzi, Laura, Coen, Massimo, Orlando, Giovanna, Di Matteo, Sergio, Colombo, Giorgio L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448455/ https://www.ncbi.nlm.nih.gov/pubmed/23028230 http://dx.doi.org/10.2147/TCRM.S33674 |
Ejemplares similares
-
Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
por: Rizzardini, Giuliano, et al.
Publicado: (2012) -
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)
por: Restelli, Umberto, et al.
Publicado: (2015) -
Trends in hospital admissions at a Department for Infectious Diseases in Italy from 1995 to 2011 and implications for health policies
por: Orlando, Giovanna, et al.
Publicado: (2014) -
Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2013) -
Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
por: Foglia, Emanuela, et al.
Publicado: (2014)